Remdesivir as a possible therapeutic option for the COVID-19.
Identifieur interne : 000743 ( PubMed/Corpus ); précédent : 000742; suivant : 000744Remdesivir as a possible therapeutic option for the COVID-19.
Auteurs : Jaffar A. Al-Tawfiq ; Ali H. Al-Homoud ; Ziad A. MemishSource :
- Travel medicine and infectious disease [ 1873-0442 ] ; 2020.
DOI: 10.1016/j.tmaid.2020.101615
PubMed: 32145386
Links to Exploration step
pubmed:32145386Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Remdesivir as a possible therapeutic option for the COVID-19.</title>
<author><name sortKey="Al Tawfiq, Jaffar A" sort="Al Tawfiq, Jaffar A" uniqKey="Al Tawfiq J" first="Jaffar A" last="Al-Tawfiq">Jaffar A. Al-Tawfiq</name>
<affiliation><nlm:affiliation>Infectious Disease Unit, Specialty Internal Medicine and Infection Control Unit, Quality and Patient Safety, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: jaffar.tawfiq@jhah.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Al Homoud, Ali H" sort="Al Homoud, Ali H" uniqKey="Al Homoud A" first="Ali H" last="Al-Homoud">Ali H. Al-Homoud</name>
<affiliation><nlm:affiliation>Pharmacy Services Division, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Memish, Ziad A" sort="Memish, Ziad A" uniqKey="Memish Z" first="Ziad A" last="Memish">Ziad A. Memish</name>
<affiliation><nlm:affiliation>Director Research Center, King Saud Medical City, Ministry of Health, Saudi Arabia; Al-Faisal University, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32145386</idno>
<idno type="pmid">32145386</idno>
<idno type="doi">10.1016/j.tmaid.2020.101615</idno>
<idno type="wicri:Area/PubMed/Corpus">000743</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000743</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Remdesivir as a possible therapeutic option for the COVID-19.</title>
<author><name sortKey="Al Tawfiq, Jaffar A" sort="Al Tawfiq, Jaffar A" uniqKey="Al Tawfiq J" first="Jaffar A" last="Al-Tawfiq">Jaffar A. Al-Tawfiq</name>
<affiliation><nlm:affiliation>Infectious Disease Unit, Specialty Internal Medicine and Infection Control Unit, Quality and Patient Safety, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: jaffar.tawfiq@jhah.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Al Homoud, Ali H" sort="Al Homoud, Ali H" uniqKey="Al Homoud A" first="Ali H" last="Al-Homoud">Ali H. Al-Homoud</name>
<affiliation><nlm:affiliation>Pharmacy Services Division, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Memish, Ziad A" sort="Memish, Ziad A" uniqKey="Memish Z" first="Ziad A" last="Memish">Ziad A. Memish</name>
<affiliation><nlm:affiliation>Director Research Center, King Saud Medical City, Ministry of Health, Saudi Arabia; Al-Faisal University, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Travel medicine and infectious disease</title>
<idno type="eISSN">1873-0442</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32145386</PMID>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>11</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-0442</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Mar</Month>
<Day>05</Day>
</PubDate>
</JournalIssue>
<Title>Travel medicine and infectious disease</Title>
<ISOAbbreviation>Travel Med Infect Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Remdesivir as a possible therapeutic option for the COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>101615</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1477-8939(20)30083-1</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tmaid.2020.101615</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Tawfiq</LastName>
<ForeName>Jaffar A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo><Affiliation>Infectious Disease Unit, Specialty Internal Medicine and Infection Control Unit, Quality and Patient Safety, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: jaffar.tawfiq@jhah.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Al-Homoud</LastName>
<ForeName>Ali H</ForeName>
<Initials>AH</Initials>
<AffiliationInfo><Affiliation>Pharmacy Services Division, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Memish</LastName>
<ForeName>Ziad A</ForeName>
<Initials>ZA</Initials>
<AffiliationInfo><Affiliation>Director Research Center, King Saud Medical City, Ministry of Health, Saudi Arabia; Al-Faisal University, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>03</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Travel Med Infect Dis</MedlineTA>
<NlmUniqueID>101230758</NlmUniqueID>
<ISSNLinking>1477-8939</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CoiStatement>Declaration of competing interest All authors have no conflicts of interest.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>02</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>02</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>03</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>3</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>3</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>3</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32145386</ArticleId>
<ArticleId IdType="pii">S1477-8939(20)30083-1</ArticleId>
<ArticleId IdType="doi">10.1016/j.tmaid.2020.101615</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000743 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000743 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV2 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:32145386 |texte= Remdesivir as a possible therapeutic option for the COVID-19. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:32145386" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidV2
This area was generated with Dilib version V0.6.33. |